HCM - hutch-med.com Revenue Growth Rate YoY (Last Twelve Months)

Public company logo of HUTCHMED Corp (HCM)

HUTCHMED (China) Limited's TTM annual revenue growth rate correlates with the expansion of fruquintinib and the alliance with Takeda, while -8.90 shows the value of this parameter. Environmental responsibility is demonstrated through energy-efficient plants and wastewater treatment. Business stability relies on the success of clinical trials in the US and China, coupled with strict control over R&D expenses.

Hutchison MediPharma (HCM) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

HUTCHMED (HCM) - metric breakdowns and financial figures

- market value and analyst target forecast:
Summary company analytics:HUTCHMED (China) Limited
Product sample of hutch-med.com

A fundamental valuation of HUTCHMED (China) Limited (HCM) requires an analysis of the scaling rates of its innovative drug portfolio. This indicator measures daily revenue dynamics over a rolling year, capturing operational activity and identifying stagnation or anomalous spikes. By analyzing this chart of 12-month YoY sales changes, an investor can discern the expansion speed of targeted therapies across global markets. Growth in this metric confirms the commercial success of oncology developments, although extreme peaks may signal currency risks.

Competitors of HUTCHMED (China) Limited (HCM)

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|NUVB - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Day One|MNPR: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Inhibrx Biosciences Inc INBX|Revenue Growth YoY (Last 12 Months) IMAB|Trailing Twelve Months Revenue Growth Fennec Pharmaceuticals FENC|Revenue Growth YoY (Last 12 Months) HRTX (Heron)|NVCT (Nuvectis Pharma) - Revenue Dynamics YoY (Last Twelve Months)|Coherus Biosciences - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)